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Objectives: The characterization of differential gene expression in Giardia lamblia WB C6 strain C4
resistant to metronidazole and nitazoxanide using microarray technology and quantitative real-time
PCR.
Methods: In a previous study, we created and characterized the G. lamblia WB C6 clone C4 resistant to
nitazoxanide and metronidazole. In this study, using a microarray-based approach, we have identified
open-reading frames (ORFs) that were differentially expressed in C4 when compared with its wild-type
WB C6. Using quantitative real-time PCR, we have validated the expression patterns of some of those
ORFs, focusing on chaperones such as heat-shock proteins in wild-type and C4 trophozoites. In order
to induce an antigenic shift, trophozoites of both strains were subjected to a cycle of en- and excysta-
tion. Expression of selected genes and resistance to nitazoxanide and metronidazole were investigated
after this cycle.
Results: Forty of a total of 9115 ORFs were found to be up-regulated and 46 to be down-regulated in
C4 when compared with wild-type. After a cycle of en- and excystation, resistance of C4 to nitazoxa-
nide and metronidazole was lost. Resistance formation and en-/excystation were correlated with
changes in expression of ORFs encoding for major surface antigens such as the variant surface
protein TSA417 or AS7 (‘antigenic shift’). Moreover, expression patterns of the cytosolic heat-shock
protein HSP70 B2, HSP40, and of the previously identified nitazoxanide-binding proteins nitroreduc-
tase and protein disulphide isomerase PDI4 were correlated with resistance and loss of resistance after
en-/excystation. C4 trophozoites had a higher thermotolerance level than wild-type trophozoites. After
en-/excystation, this tolerance was lost.
Conclusions: These results suggest that resistance formation in Giardia to nitazoxanide and metroni-
dazole is correlated with altered expression of genes involved in stress response such as heat-shock
proteins.
Keywords: drug resistance, microarray analysis, differential gene expression, antigenic variation, encystation,
excystation
Introduction
Giardia lamblia (syn. Giardia duodenalis; Giardia intestinalis),
a flagellated protozoan, is the most common causative agent of
persistent diarrhoea worldwide.1 The life cycle of G. lamblia
includes two major stages: the proliferative trophozoite and the
non-proliferative, infectious cyst. Infection occurs upon peroral
ingestion of cysts. Following excystation in the upper part of the
small intestine, cysts release an excyzoite, a transient stage of
the life cycle, immediately dividing into four trophozoites.2
As demonstrated in vitro in the case of G. lamblia isolate WB,
clone C6, the process of excystation coincides with a change in
the expression of the major surface antigens, namely variant
surface proteins (VSPs).3
Since metronidazole (commercially known as Flagylw) and
other nitroimidazoles efficiently kill Giardia trophozoites in
vitro, these drugs have been used as therapy of choice against
giardiasis.4,5 Metronidazole efficiently enters giardial tropho-
zoites and is supposed to be reduced into a toxic nitro radical
by the metabolic anaerobic enzyme pyruvate:ferredoxin
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oxidoreductase (POR).6 Resistance to metronidazole and other
nitroimidazoles has been induced in vitro, and various genotypi-
cally distinct isolates with reduced drug susceptibility have also
been found in human patients.4,7 Formation of giardial resistance
to metronidazole is associated with down-regulation of the POR
activity.5 This is consistent with the involvement of POR in
metronidazole activation.8
In the mid-1990s, a new antiparasitic agent, the thiazolide
nitazoxanide (commercially known as Aliniaw), was introduced
to the market.9,10 Nitazoxanide, a nitrothiazolyl-salicylamide, is
the first agent with proven efficacy against cryptosporidiosis and
has been approved in the USA for the treatment of cryptospori-
diosis and giardiasis in children and adults.9 Upon oral uptake,
nitazoxanide is rapidly deacetylated to tizoxanide and further
metabolized to tizoxanide–glucoronide.9 Tizoxanide has been
reported to display antimicrobial activity similar to nitazoxanide,
whereas tizoxanide–glucuronide is largely inactive against a
number of pathogens.11 Tizoxanide and tizoxanide–glucuronide
are further metabolized, or excreted, in urine and/or bile and
faeces.
Thiazolides without the thiazole-associated nitro group have
been shown to exhibit decreased efficacy against Giardia.12,13
Therefore, an involvement of the nitro group in the mechanism
of action, with the participation of POR similar to metronida-
zole, has been postulated.14 The nitro group is also required for
the in vitro activity against anaerobic bacteria.15 In G. lamblia,
we have identified and characterized a nitroreductase (NR) as a
nitazoxanide-binding protein.16 Inhibition of the anaerobic
energy metabolism through nitazoxanide by interfering in func-
tional activity of POR has recently been reported for other proto-
zoan parasites,17 but this process is thought to be only one of
several pathways by which the drug exhibits antiprotozoal
activity.9 In fact, more recent studies have shown that nitazoxa-
nide derivatives lacking the nitro group exhibit profound in vitro
activity against intracellular pathogens such as Neospora
caninum, Cryptosporidium parvum and Besnoitia besnoiti,11,18
suggesting that the nitro group is not required for the activity
against intracellular parasites.
In order to elucidate the biochemical nature of resistance for-
mation to nitazoxanide and metronidazole, we have generated
metronidazole- and nitazoxanide-resistant G. lamblia clones and
compared them to the wild-type WB C6 with respect to their
growth behaviour and to the expression pattern of genes that are
potentially involved in resistance formation.19 In order to identify
novel genes that could be involved in resistance formation, we
have chosen a microarray-based screen in order to identify genes
that are differentially expressed in the previously characterized,
double-resistant strain C4 by a factor of 4 or more when compared
with wild-type trophozoites. Some of the positive hits were then
further investigated by RT–PCR in independent experiments.
Respective gene expression patterns were also determined for tro-
phozoite populations that, after a cycle of en- and excystation, had
completely lost resistance to both nitazoxanide and metronidazole.
Materials and methods
Tissue culture media, biochemicals and drugs
Unless otherwise stated, all biochemical reagents were from Sigma
(St Louis, MO, USA). Nitazoxanide was synthesized at the
Department of Chemistry and Biochemistry, University of Berne
(C. Leumann). The structural formulas are described elsewhere.13
Nitazoxanide and metronidazole were kept as 100 mM stock sol-
utions in DMSO at 48C.
Axenic culture of Giardia trophozoites and en-/excystation
of the parasite
Trophozoites from G. lamblia WB clone C6 were grown under
anaerobic conditions in 10 mL culture tubes (Nunc, Roskilde,
Denmark) containing modified TYI-S-33 medium as described pre-
viously.13 In order to initiate subcultures, cultures with confluent
trophozoite lawns were incubated on ice for 15 min. Suspended
living (adherent) trophozoites were counted (Neubauer chamber,
200). Subcultures were initiated by adding 104 trophozoites to a
new culture tube. The double-resistant clone C4 was cultivated in
the presence of 40 mM nitazoxanide.
In vitro induction of encystation of the parasite was performed as
described previously.20 For in vitro excystation, 2-day encysting
cells were water-treated at 48C to destroy trophozoites and any
incompletely formed cysts. Approximately, 1  105 of pre-treated
cysts were excysted by using a two-step procedure that included:
(i) a 20 min incubation at 378C in a low pH excystation solution
(pH 4.0) containing reduced glutathione and L-cysteine in Hanks
buffer (stage I) and (ii) a 1 h of incubation at 378C in excystation
stage II solution (pH 8.0) containing 1 mg/mL trypsin (Type 2,
from porcine pancreas, Sigma) in Tyrode’s salt solution.21 Excysted
trophozoites were grown in drug-free, modified TYI-S-33 medium
until near confluency was reached and then subcultivated in order to
test both drug resistance and thermotolerance as described below.
In order to determine the IC50 values of different G. lamblia
lines, 10 mL trophozoite cultures were grown at different drug con-
centrations as described previously.13 For thermotolerance exper-
iments, trophozoites were inoculated in 24-well plates (104 in 1 mL
medium per well) and incubated for 2 days in anaerobic growth
chambers at temperatures ranging from 37 to 438C.
Processing of RNA samples and cDNA synthesis
To quantify gene expression by real-time RT–PCR, trophozoites of
wild-type WB C6 and resistant clone C4 were grown until near
confluency was reached. Cells were harvested as described, and
RNA was extracted using the Qiagen RNeasyTM kit, including
a DNase I digestion (to remove residual genomic DNA) according
to the instructions provided by the manufacturer. RNA was eluted
with 50 mL of RNase-free water and stored at 2808C.
Synthesis of cDNA for quantitative RT–PCR was performed
using the Qiagen OmniscriptTM kit as described.
For synthesis of aminoallyl-cDNA for microarray analysis, the
reaction mixture contained 5 mL of Omniscript buffer 10, 2.5 mL
of random primer (Promega), 0.6 mL of RNAsin (40 U/mL;
Promega), 2.5 mL of Omniscript RTase, 0.6 mL of dNTP (25 mM;
aminoallyl-dUTP 2:1), 5 mL of DTT (0.1 M), 1 mg of RNA and
water of highest purity in a total volume of 50 mL. The reaction was
incubated overnight at 378C. Then the reaction was stopped by
adding 10 mL of EDTA (0.5 M) and 10 mL of NaOH (1 M). The
reaction was incubated for 10 min at 658C in order to hydrolyse
RNA and was neutralized by adding 30 mL of Tris Cl2 (1 M, pH
7). Aminoallyl-cDNA was purified using a Roche PCR purification
kit (Roche, Basel, Switzerland). Then, 500 mL of binding buffer
from the kit was added to the sample, and the sample was applied
to the column and centrifuged. In order to avoid the carry-over of
amino groups to the subsequent labelling reaction, the column was
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washed first with 500 mL and then with 200 mL of phosphate wash
buffer (5 mM K-PO4, pH 8.5, 80% EtOH). Subsequently, cDNA
was eluted with 2 50 mL of phosphate elution buffer (4 mM
K-PO4, pH 8.5), lyophilized and stored at –208C.
Dye labelling of aminoallyl-cDNA
For dye labelling,22 lyophilized aminoallyl-cDNA was suspended in
5 mL of 100 mM NaCO3, pH 9.3. The appropriate dye, namely Cy3
or Cy5 mono-reactive (GE Healthcare, Little Chalfont, UK), was
dissolved in 75 mL of DMSO, and 5 mL was added to the cDNA.
The remaining dye was stored at –208C. The reaction was incubated
for 2 h at room temperature in the dark and stopped by adding
35 mL of 100 mM Na-Acetate, pH 5.2. Dye-labelled cDNA was
purified by Roche PCR purification kit according to the protocol.
Eluted cDNA was lyophilized and stored in the dark until microar-
ray hybridization.
Microarray hybridization
The microarrays were kindly provided by the Pathogen Functional
Genomics Research Center (J. Craig Venter Institute, Rockville,
MD, USA). The arrays (Giardia lamblia microarrays version 1) con-
tained 19 230 elements consisting of duplicates of 70-mer oligomers
derived from 9115 predicted open-reading frames (ORFs) including
the clearly identified 6470 ORFs of the genome of G. lamblia WB
C623 as described in the Giardia database24 and of 500 Arabidopsis
thaliana control oligomers. To pre-hybridize, slides were incubated
in Falcon tubes containing 50 mL of 5 SSC, 0.1% SDS and
12.5 mg of herring sperm DNA at 558C for 1 h. Slides were then
washed in deionized water for 2 min at continuous shaking. Washes
were repeated five to six times. Slides were then dipped into isopro-
panol for 2 min, dried under an air-stream and immediately
hybridized.
For hybridization, labelled aminoallyl-cDNAs were dissolved in
30 mL of hybridization buffer, i.e. sterile-filtered pre-hybridization
buffer containing 0.1 mM DTT and denatured for 10 min at 958C
followed by cold shock on ice. For each hybridization, one Cy3-
and one Cy5-labelled cDNA were combined yielding 60 mL of
probe mix. Then, 40 mL of probe mix was added to a pre-hybridized
slide and covered with a 24  60 mm clean, isopropanol washed,
dry cover slip.
Slides were then placed into a 50 mL Falcon tube on top of a
paper strip wetted with hybridization buffer, placed horizontally into
a 558C oven and incubated for 3 h.
After hybridization, slides were dipped into low stringency
buffer (2 SSC, 0.1% SDS) until the cover slip loosened and
washed at low stringency for another 20 min, followed by a wash at
medium stringency (1 SSC) for another 20 min and a wash at
high stringency (0.1 SSC, 2% EtOH) for another 5 min. All
washes were performed at room temperature in the dark. Slides were
then dried in an air-stream and scanned with a GenePix Personal
4000B scanner (Molecular Devices, Sunnyvale, CA, USA).
Annotation and evaluation of the hybridized slides were performed
using the GenePix Pro software package. Two independent hybridiz-
ations (two screens) were performed. Prior to analysis, signals were
normalized by the GenePix Pro software. Signal strengths were
defined as median feature pixel intensity minus the median feature
background intensity at 535 nm (Cy3-labelled probes) or 632 nm
(Cy5-labelled probes). For the screens presented here, only signal
strengths higher than 800 were retained. The corresponding ORFs
were regarded as differentially expressed when the ratio between
signals at 535 and 632 nm was higher than 4.
Quantitative RT–PCR
First-strand cDNA was synthesized using the Qiagen OmniscriptTM
RT kit as described by the manufacturer with a polyT-ANC
primer25 for subsequent real-time PCR (for primer sequences, see
Table 1). Quantitative PCR was performed with 4 mL of 1:100
diluted cDNA using the Quanti TectTM SYBR Green PCR Kit
(Qiagen) in a 10 mL standard reaction containing a 0.5 mM concen-
tration of forward and reverse primers (MWG Biotech, Ebersberg,
Germany). Furthermore, a control PCR included RNA equivalents
from samples that had not been reverse transcribed into cDNA (data
not shown) to confirm that no DNA was amplified from any residual
genomic DNA that might have resisted DNase I digestion (see
above). PCR was started by initiating the ‘Hot-Start’ Taq
DNA-polymerase reaction at 958C (15 min). Subsequent DNA
amplification was performed in 40 cycles including denaturation
(948C for 15 s), annealing (608C for 30 s) and extension (728C for
30s); temperature transition rates in all cycle steps were 208C/s.
Fluorescence was measured at 798C (TSA417 and VSPtot-PCR) or
828C (all other PCRs listed in Table 1) during the temperature shift
after each annealing phase. For statistical analysis, five independent
experiments were performed. Expression levels of the genes
summarized in Table 1 were given as values in arbitrary units
relative to the amount of constitutively expressed ‘house keeping’
gene ACT.
Statistics
IC50 values were calculated after to the logit–log transformation of
the relative growth (RG; control ¼ 1) according to the formula
ln[(RG/(1 2 RG)] ¼ a  ln(drug concentration) þ b and subsequent
regression analysis. Regression analysis, analysis of variance and
subsequent pairwise t-tests were performed using the corresponding
software tool contained in the Excel software package (Microsoft,
Seattle, WA, USA).
Results
Microarray screen for differentially expressed ORFs
In order to identify differentially expressed ORFs in the
nitazoxanide-resistant clone C4 versus wild-type cells, as a first
step, two microarray-based screens were performed [Figure S1,
available as Supplementary data at JAC Online (http://jac.oxford-
journals.org/)]. We considered ORFs as up- or down-regulated,
when in at least one screen, a .4-fold difference between wild-
type and C4 cDNA hybridization signals (log2 ratio of wild-type
versus C4 signals .2 or ,22) was found. The mRNA corre-
sponding to 40 ORFs was found to be up-regulated in C4 versus
wild-type cells, and the mRNA corresponding to 46 ORFs
was found to be down-regulated in C4 versus wild-type cells
(Table 2).
Besides variable surface antigens, ORFs encoding for pro-
teins potentially involved in cell signalling such as protein
kinases and phosphatases were differentially regulated in wild-
type versus C4 trophozoites. More striking were the differences
in ankyrin-domain proteins (protein 21.1) with eight ORFs
being up-regulated and one down-regulated, and chaperonins
with five up-regulated ORFs. Among the chaperones ORFs
up-regulated in C4 versus wild-type, three were heat-shock pro-
teins (one HSP70 and two HSP90).
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Expression of chaperone genes
Given the custom-made nature of the microarrays, we validated
the results obtained in the two screens by quantitative real-time
RT–PCR assays using reverse transcripts of actin (ACT) as
reference for the amount of total cDNA. The gene expression
level of actin was not affected in the clone C4 when compared
with the wild-type (see Mu¨ller et al.13). In a first study, quanti-
tative real-time PCR was performed on chaperone ORFs that
were found positive in the screens. As a non-chaperonin, we
included one ankyrin ORF (protein 21.1.). The cytosolic HSP70
isoform B2 transcript had the highest expression level of all
chaperones, and was nearly 10 times higher in C4 than in wild-
type cells. HSP90 was expressed at levels three orders of magni-
tude lower. Expression was nearly three times higher in C4
(Figure 1a). Co-chaperone p23, chaperonin 60 and protein 21.1
had expression levels one order of magnitude lower than HSP70
Table 1. Overview of primers used in this study
Gene, accession number or ORF Region of CDS Primer (50!30)
21.1 protein (21.1) ORF:12 139 CDS 1773–2046 plus 16 of 30 utr 12139F GAACGACCGCACTCATGGA
12139R GGTCCACACGCCGTGTTC
Actin (ACT) EAA39190 CDS 715–933 ACTquantF ACATATGAGCTGCCAGATGG
ACTquantR TCGGGGAGGCCTGCAAAC
Chaperonin cpn60 (cpn60) ORF:7031 CDS 2744–2988 plus 14 of 30 utr 7031F CTAACACGGCATCGGTACCA
7031R GTTTCAATCCTAAATCACGGT
Co-chaperone p23 (cpnp23) ORF:10429 CDS 350–558 plus 13 of 30 utr 10429F CCAACCCCAACGACATGGA
10429R AATTGCCAGGCATTTACTCCT
Cysteine rich surface antigen ORF:10659 CDS 2003–2176 plus 34 of 30 utr 10659F GGGGTGACTACAAGCTGGA
10659R CATTGGTGTGGCCGCTTAC
Cyst wall protein 1 (CWP1) XM 766142.1 CDS 367–713 CWP1quantF GGCGATATTCCCGAGTGCATGTG
CWP1quantR GTGAGGCAGTACTCTCCGCAGT
Glutamate dehydrogenase (GDH)
XM_773614
CDS 761–893 GDHquantF AGGTCCTCACCTTCTCAGACT
GDHquantR GGATACTTGTCCTTGAACTCGG
Heat-shock protein 40 (hsp40) ORF:17483 CDS 817–990 plus 28 of 30 utr 17483F GTATCAGAGGTCATCATCCC
17483R CGAAAAGCAGGAGTAGGGG
Heat-shock protein 70 B2, cytosolic form
(hsp70B2) ORF:88765
CDS 1818–1995 plus 16 of 30 utr 88765F GAGGCGATCGTCCATCCC
88765R CCTTACACCACAGTTAGTCC
Heat-shock protein 70, ER form (erhsp70)
ORF:17121
CDS 2204–2434 plus 45 of 30 utr 17121F AACATCGTTGACAAGATCTCC
17121R CATTGGTTAGTTTACAAGACCT
Heat-shock protein 70, mitochondrial
form (mthsp70) ORF:14581
CDS 1733–1923 plus 55 of 30 utr 14581F TCTTGTCCAAAGATATCGTGG
14581R GGATGGGCGGCAGATACC
Heat-shock protein 90 (hsp90_1)
ORF:13864
CDS 752–975 plus 27 of 30 utr 13864F ACGACGACGCAGAGAACCT
13864R CAAAGTAACACAACAAGTTCAC
Heat-shock protein 90 (hsp90_2)
ORF:98054
CDS 846–1051 plus 39 of 30 utr 98054F CCGAGGACGAGTACAAGGA
98054R GGGGTGTACTTGTTGCACC
Nitroreductase (NR) EAA43030.1 CDS 526–794 plus 8 of 30 utr NRquantF CCTGCTGACAAGGCCGCA
NRquantR AACACCAATTACTTAAATGTAATG
Protein disulphide isomerase 2 (PDI2)
EAA42483.1
CDS 1055–1350 plus 13 of 30 utr PDI2quantF GGCCCAGGGCGAGGAGT
PDI2quantR AGACAAGAACCGTTTACTTCTT
Protein disulphide isomerase 4 (PDI4)
AF295634.1
CDS 775–1065 plus 1 of 30 utr PDI4quantF CCGAAGGACGAGACTTCCT
PDI4quantR CTCAGAGCTCCTTGTCCCC
Pyruvate oxidoreductase 1 (POR1)
ORF:17063
CDS 3341–3600 plus 9 of 30 utr POR1quantF ATCCAACGCGACCCAGAAG
POR1quantR GTTCACTGCTTACTCCGCC
Pyruvate oxidoreductase 2 (POR2)
ORF:114609
CDS 3325–3547 POR2quantF CTCGCACATGGTCCAGGG
POR2quantR AGAGCCGCAGCCATCTCC
Variant surface protein (total) see Nash and Mowatt26 VSPtotquantF (MM16) GGCTTCCTCTGCTGGTGGTTC
VSPtotquantR (ANC) GACCACGCGTATCGATGTCGA
Variant surface protein TSA417 U89152.1 CDS 127–335 TSA417quantF TGTGGAACGTGTGCCAATAG
TSA417quantR AGACACGTAGTACAGTCGG
Variant surface protein VSPAS7
ORF:137740
CDS 1171–1356 plus 25 of 30 utr 137740F TGAGCACAGACGTCGATGG
137740R ACTATCTAAGTACACAGCTAAG
Variant surface protein VSPAS7A
ORF:98058
CDS 90–264 plus 52 of 30 utr 98058F CCATCTAATAATCAAGGCTCC
98058R AGTGGGCAGGTGCAATAGG
CDS, coding sequence; ORF, referring to Giardia database24; utr, untranslated.
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Table 2. Overview of ORFs expressed in nitazoxanide/metronidazole double-resistant C4 trophozoites with a .4-fold difference to
wild-type trophozoites in at least one of two independent microarray-based screens
(Hypothetical) function Protein
ORF number in
Giardia database
Log2 ratio
(C4/wild-type)
screen 1 screen 2
Up-regulated in C4 versus wild-type
Chaperonin co-chaperone p23 homologous 10429 2.31 3.18
heat-shock protein 70 B2 88765 2.62 3.49
heat-shock protein 90 13864 1.98 2.85
98054 1.88 2.75
spindle pole associated chaperonin 60 7031 1.96 2.83
Cytoskeleton, adhesion and
organelle transport
ankyrin-repeat proteins (protein 21.1) 8174 1.26 2.13
12139 2.26 3.13
14859 1.66 2.67
16532 1.80 2.66
17046 1.89 2.76
17551 1.91 2.78
27925 2.02 2.89
giardin 4812 1.75 2.62
Intermediary metabolism carbamate kinase 16453 1.77 2.64
cysteine protease 114773 1.22 2.80
Protein (de) phosphorylation CDC14 phosphatase 9270 1.22 2.19
NAF-domain containing protein kinase 16235 1.37 2.24
NimA related protein kinase 8445 1.33 2.20
protein kinase family protein 17558 1.38 2.25
thymidine kinase 8364 1.46 2.33
Surface antigen variant specific surface protein AS7 137740 1.24 2.10
variant specific surface protein VSP9B10 115066 1.28 2.15
VSP; cysteine rich protein 38901 1.01 2.46
hypothetical protein (17 ORFs)
Down-regulated in C4 versus wild-type
Cell division and gene
expression
bacterial-like Sir2 family protein 16569 24.08 24.50
cell division control protein 16 15248 22.57 24.41
spliceosome-associated protein 13464 22.58 23.52
valyl-tRNA synthetase 35428 21.47 22.75
Cytoskeleton, adhesion and
organelle transport
ankyrin-repeat proteins (protein 21.1) 14872 23.86 28.35
dynein regulatory complex 16540 21.71 23.24
kinesin-9 6404 23.86 28.21
Intermediary metabolism N-acetyl-glucosaminyl-phosphatidylinositol
synthesis protein
113610 24.81 27.91
cathepsin-L-like protease 9548 23.37 23.04
Protein (de) phosphorylation serine/threonine protein kinase SKS1 14578 22.86 22.66
Surface antigen trophozoite cysteine rich surface antigen 170 24391 22.52 21.65
trophozoite cysteine-rich surface antigen 72 111874 22.11 21.23
113954 22.26 21.39
variant specific surface protein 417 97820 23.21 22.34
113797 23.72 22.85
variant specific surface protein AS12 114672 22.20 21.33
variant-specific surface protein 113450 23.13 22.26
variant-specific surface protein AS7A 98058 22.48 21.61
hypothetical protein (28 ORFs)
Log2 ratio (C4/wild-type) corresponds to the mean value of two technical replicates of the signal strengths of C4 cDNA versus wild-type cDNA in two
independent microarray-based screens.
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with a more than four times higher expression in C4 than
in wild-type, thus fully confirming the microarray results
(Figure 1b).
In order to check whether heat-shock protein ORFs that
were not retained in the screens were also overexpressed in C4
when compared with wild-type trophozoites, the expression
of the endoplasmic reticulum (ER) isoform of HSP70,27 the
putative mitochondrial HSP7028 and HSP4024 was analysed by
RT–PCR. The HSP70 ER isoform was up-regulated by a factor
2 in C4 versus wild-type trophozoites. Conversely, the mito-
chondrial HSP70 isoform and HSP40 isoform had similar
expression levels in wild-type and C4 (Figure 2).
Loss of resistance and antigenic shift after en-/excystation
During long-term culture over 30 generations in the absence of
a drug, C4 maintained a significant degree of resistance to nita-
zoxanide and metronidazole. During this time, the expression
profile of some selected genes such as HSP70 B2, NR and
others, as well as the expression of the major surface trophozoite
antigen 417 (TSA417), did not change markedly [Figures S2,
S3, S4 and S5, available as Supplementary data at JAC Online
(http://jac.oxfordjournals.org/)]. Therefore, in order to induce a
stage conversion and to test the stability of nitazoxanide/metro-
nidazole double resistance in G. lamblia clone C4, C4 as well as
Figure 1. Quantification of gene expression in wild-type (WT) and nitazoxanide/metronidazole-resistant (C4) trophozoites and in the same lines (WTEX
and C4EX) after en-/excystation by RT–PCR. Trophozoites were grown in normal culture medium until near confluency was reached. RNA was extracted and
reverse transcribed to cDNA. Transcripts of the heat-shock protein genes encoding for the cytosolic HSP70 B2 (ORF:88765), HSP90_1 (ORF:13864) and
HSP90_2 (ORF:98054) (a), and the chaperonins co-chaperonin p23 (ORF:10429) and chaperonin 60 (ORF:7031) and an ankyrin protein 21.1 (ORF:12139)
(b) were quantified in relation to actin mRNA. The relation is expressed in arbitrary units. Mean values (+SE) of five independent experiments are given.
Different letters indicate statistically significant differences (ANOVA followed by pairwise t-tests; P, 0.01). Note the differences in scales of ordinates.
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wild-type WB C6 trophozoites were subjected to one cycle of
en- and excystation and were subsequently tested for growth in
the presence of different drug concentrations (see the Materials
and methods section). Both en- and excystation of clone C4
were conducted in the absence of the two drugs, since in the
presence of the compounds, trophozoites of this strain did not
encyst.19 In this experiment, en-/excysted C4 trophozoites exhib-
ited IC50 values (5.8+ 1.1 mM nitazoxanide and 3.1+ 1.7 mM
metronidazole) similar to those of wild-type clone WB C6
(4.2+ 1.2 mM nitazoxanide and 5.8+1.4 mM metronidazole)
and of en-/excysted WB C6 (2.5+ 1.0 mM nitazoxanide and
2.3+ 1.4 mM metronidazole). However, these values were much
lower than those determined for the original clone C4 (33.8+
1.1 mM nitazoxanide and 38+ 2.5 mM metronidazole). This
observation indicated that upon completion of the life cycle,
G. lamblia clone C4 had completely lost both nitazoxanide and
metronidazole resistance.
As expected, en-/excystation was followed by an antigenic
shift, the major surface antigen of WB C6, VSP417 being
almost completely down-regulated (Figure 3) as in the resistant
clone C4 before en-/excystation. After en-/excystation, C4 did
not shift back to VSP417. The same was observed for a
cysteine-rich surface antigen strongly down-regulated in C4 tro-
phozoites and wild-type trophozoites after excystation. Instead,
other surface antigens such as VSPAS7 and VSPAS7A were
expressed (Figure 3).
Interestingly, after en-/excystation of C4 trophozoites, differ-
ences in expression of HSP and chaperonin-like genes reached
levels similar to wild-type or en-/excysted wild-type trophozoites
(Figures 1 and 2). In some cases (co-chaperone p23, chaperonin
60 and protein 21.1), en-/excysted wild-type trophozoites had
significantly higher values than wild-type trophozoites, whereas
values in C4 trophozoites were similar or lower after than before
en-/excystation (Figure 1b). In one case, namely HSP90_2,
expression levels in en-/excysted trophozoites were significantly
lower than before en-/excystation (Figure 1a).
Moreover, the expression of genes encoding nitazoxanide-
binding proteins such as NR, pyruvate oxidoreductases (POR1
and POR2) and protein disulphide isomerases (PDI2 and PDI4)
was investigated in all four strains. As described previously,13
the expression level of NR was significantly lower, but the
expression levels of PDI2 and PDI4 were higher in C4 than in
wild-type trophozoites. Upon en-/excystation, differences in NR
and PDI4 expression were lost (Figure 4). Expression of the two
POR genes showed only slight differences between all strains. In
en-/excysted C4 trophozoites, POR2 expression was significantly
lower than before en-/excystation. Conversely, expression of the
gene encoding for the cyst wall protein CWP1 was significantly
decreased in C4 when compared with wild-type trophozoites.
After en-/excystation, expression levels were significantly
decreased when compared with levels before en-/excystation
(Figure 4).
Thermotolerance
The constitutive expression of heat-shock proteins, most notably
of the highly expressed cytosolic isoform of HSP70 (B2), may
cause thermotolerance. Thus, we inoculated 24-well plates with
104 wild-type and C4 trophozoites and cultured them at tempera-
tures ranging from 37 to 438C. After 2 days, the trophozoites
grown at 378C were confluent with a density of ca. 1.7  106
per well (Figure 5). After 2 days of culture at 398C, C4 tropho-
zoites had grown up to 80% of their 378C-cell density, whereas
the proliferation of wild-type trophozoites was severely
impaired, reaching only 45% of the 378C levels. After culture at
418C, C4 trophozoites exhibited proliferation to 7% of their
378C-cell density, whereas the cultures of wild-type trophozoites
as well as en-/excysted trophozoites of both lines had died off
and trophozoites were not detected anymore. At 438C, no
growth was observed in either cell line (Figure 5). Thus, the
nitazoxanide/metronidazole double-resistant clone C4 was con-
sidered to be relatively thermotolerant when compared with the
Figure 2. Quantification of heat-shock protein gene expression by RT–PCR
in wild-type (WT), nitazoxanide/metronidazole-resistant (C4) trophozoites
and in the same lines (WTEX and C4EX) after en-/excystation. Trophozoites
were grown in normal culture medium until near confluency was reached.
RNA was extracted and reverse transcribed to cDNA. Transcripts of the
genes encoding for the ER and mitochondrial HSP70s (ORF:17121 and
ORF:14581) and HSP40 (ORF:17483) were quantified in relation to actin
mRNA. The relation is expressed in arbitrary units. Mean values (+SE) of
five independent experiments are given. Different letters indicate statistically
significant differences (ANOVA followed by pairwise t-tests; P, 0.01).
Note the differences in scales of ordinates.
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respective wild-type, en-/excysted lines of C4 and wild-type
trophozoites.
Discussion
In a previous study, we characterized the nitazoxanide/
metronidazole double-resistant G. lamblia trophozoite clone C4
and the metronidazole-resistant clone C5.19 In the present
study, we performed two initial microarray screens in order to
identify genes that were up- or down-regulated by a factor of 4
or more in C4 versus wild-type trophozoites. The differences
in surface antigen expression observed in the microarray
screen, especially the down-regulation of the trophozoite major
surface-labelled trophozoite antigen 417 precursor (TSA417),
confirm our previous results. A completely different pattern
of up- and down-regulated mRNAs was observed in other
lines such as the formononetin-resistant line C3 or the
metronidazole-resistant strain C5. The only annotated ORFs
down-regulated in all screens encoded the major surface tro-
phozoite antigen 417 (TSA417), thus confirming previous
results (data not shown). Clone C5 exhibits a slower growth
capacity compared with C4, with a more pronounced lag
phase. In addition, clone C5 does not excyst in vitro.
Therefore, clone C5 cannot be directly compared with C4 and
was not included in the present work.19 Moreover, we have
identified vsp genes that were up-regulated following the anti-
genic switch in clone C4. In addition, genes potentially
involved in protein phosphorylation and network formation,
especially ankyrins,29–31 and chaperonins were up-regulated in
clone C4.
In this study, we have investigated the expression of chaper-
ones in more detail using RT–PCR. The chaperone with the
highest expression level in clone C4 is the cytosolic form of
HSP70.27,28 Other HSPs such as HSP40, HSP90 and the ER
isoform of HSP70 were also up-regulated in C4.
Figure 3. Antigenic variation in wild-type (WT) and nitazoxanide/metronidazole-resistant (C4) trophozoites and in the same lines (WTEX and C4EX) after en-/
excystation. Trophozoites were grown in normal culture medium until near confluency was reached. RNA was extracted and reverse transcribed to cDNA.
Transcripts of the genes encoding for VSPtotal, VSP TSA417, a cysteine-rich surface antigen (ORF:10659), VSPAS7 (ORF:137740) and VSPAS7A
(ORF:98058) were quantified in relation to actin mRNA. The relation is expressed in arbitrary units. Mean values (+SE) of five independent experiments are
given. Different letters indicate statistically significant differences (ANOVA followed by pairwise t-tests; P, 0.01). Note the differences in scales of ordinates.
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The roles of these HSPs in Giardia are not well understood.
In human cells, molecular chaperones such as HSP72 and
HSP27 prevent cells from apoptosis induced by heat shock.32 If
similar mechanisms occur in Giardia, a general response to
stress via induction of chaperones could be responsible for the
increased thermotolerance as well as for the resistance to nita-
zoxanide/metronidazole treatment as observed in clone C4
in vitro.
In previous studies, we have shown that nitazoxanide inhibits
the enzymatic activities of protein disulphide isomerases from
G. lamblia19 and N. caninum,33 and that two protein disulphide
isomerase genes were up-regulated in C4 when compared with
the wild-type.19 Inhibition of protein disulphide isomerases
in vivo could lead to the formation of badly folded proteins
and thus to an impairment of central metabolic and regulatory
processes.34,35 Cells that overexpress chaperones and proteins
involved in the stabilization of subcellular structures such as
ankyrins could overcome the deleterious effects due to protein
disulphide isomerase inhibition. It is therefore possible that the
resistance phenotype is caused by amino acid substitutions in
target proteins rather than by changes in the expression level of
the genes mentioned above. These changes may be compensatory,
reducing the fitness cost of the true resistance mutation(s) but not
having a causal relationship to that phenotype.
Resistance formation correlates with the massive down-
regulation of the expression of the TSA417 gene locus, encoding
the major surface antigen (VSP C6) of WB C6. Antigenic vari-
ation in G. lamblia allows the parasite to escape the host immune
response. Moreover, G. lamblia can alter its gene expression
profile in response to environmental pressure by inducing its
Figure 4. Expression of various genes in wild-type (WT) and nitazoxanide/metronidazole-resistant (C4) trophozoites and in the same lines (WTEX and
C4EX) after en-/excystation. Trophozoites were grown in normal culture medium until near confluency was reached. RNA was extracted and reverse
transcribed to cDNA. Transcripts of the genes encoding for nitroreductase (NR, EAA43030.1), pyruvate oxidoreductases (POR1, ORF:17063; POR2, ORF:
114609), protein disulphide isomerases (PDI2, EAA42483.1; PDI4, AF295634.1) and cyst wall protein 1 (CWP1, XM 766142.1) were quantified in relation
to actin mRNA. The relation is expressed in arbitrary units. Mean values (+SE) of five independent experiments are given. Different letters indicate
statistically significant differences (ANOVA followed by pairwise t-tests; P, 0.01). Note the differences in scales of ordinates.
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encystation and subsequent excystation, and this can be carried
out in vitro using G. lamblia clone WB C6.3 Thus, we investi-
gated whether one en-/excystation cycle would render G. lamblia
clone C4 non-resistant. As expected, the vsp expression profile
was altered in all trophozoite lines upon en-/excystation.
Moreover, excysted C4 trophozoites were now sensitive to metro-
nidazole and nitazoxanide. Thus, the loss of resistance to nitazox-
anide or metronidazole following en-/excystation indicates that
resistances acquired through prolonged treatments cannot be
passed from one generation to the other via the cysts.
It is possible that the resistance mutation(s) rendered the cell
unable to encyst. The encystation procedure could have killed
the resistant population, permitting only the susceptible rever-
tants to survive the process. Moreover, en-/excystation of C4 tro-
phozoites may have put a selective pressure for rapid growth on
the trophozoites that is not compatible with high expression
levels of those genes. Concerning the genes that we have investi-
gated, only the expression patterns of HSP70 B2, NR, PDI4 and
TSA417 correlate with resistance or susceptibility to nitazoxa-
nide and metronidazole. By (unknown) adaptive mechanisms,
these genes are then down-regulated to wild-type levels and
resistance is lost. In a recent study, it has been found that the
introduction of neomycin resistance into G. lamblia trophozoites
via a transgene has led to drastic changes in gene expression
patterns including two chaperones that we have also identified
in our study.36
These results suggest that Giardia has very flexible mechan-
isms in order to respond to changes in the environment such as
drug pressure, presence of antibodies, or even to changes in
medium composition and changes to the intracellular physiology
by introduction of transgenes. Complex gene expression patterns
could be fine-tuned in order to find an optimal compromise
between speed of growth and survival. This assumption is con-
sistent with our finding that genes involved in cell division are
down-regulated in resistant C4 when compared with wild-type
trophozoites (Table 2).
A recent report suggested that epigenetic mechanisms,
probably including histone acetylation, could be responsible for
antigenic variation.37 Very recently, evolution of antibiotic
resistance initiated by increasing sublethal doses of various anti-
biotics has been attributed to epigenetic inheritance.38 Similar
adaptive gene-regulatory processes may cause the differences in
gene expression that we have observed. Another possibility is
that mutation of an unknown regulator, e.g. a transcription
factor, is responsible for the differences in expression patterns
observed. Future work will go into more detail in order to inves-
tigate these mechanisms.
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